Our basic experimental outcomes provided sufficient results to uncover a newfound mRNA/signaling pathway regulatory network of RNF139/PI3K/AKT signaling in glioma, supplying a crucial perception concerning the regulatory theory in glioma advancement and new therapeutic options of glioma diseases. This evidence concerns the gene PIK3CA and central nervous system cancer.